Please try another search
Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company’s products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, live attenuated varicella vaccine, and HIB conjugate vaccine. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.
Name | Age | Since | Title |
---|---|---|---|
Feidong Wen | 48 | 2021 | Vice Chairman |
Weimin Du | 61 | 2008 | Chairman of the Board |
Hak Ping Wu | 64 | 2021 | Independent Director |
Feidong Wen | 50 | 2021 | Vice Chairman |
Jiankai Liu | 54 | 2008 | VP & Non-Independent Director |
Zhiyun Lu | 60 | 2012 | Chairman of the Supervisory Board |
Xiang Miao | 51 | 2021 | President & Non-Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review